IL10 and atherosclerosis: Figure 6 shows the results of the thoracic/abdominal region of the aorta. The AAV/Neo-HCD-treated had the smallest cross sectional lumen area, being consistent with atherosclerosis (p<0.05). The two therapeutic treatments, both LOX1pr-hIL10-HCD and CMVpr-IL10, had significantly larger lumens than Neo-treated-HCD controls (p<0.05).